Reported Friday, Mineralys Therapeutics Showcases Broad Clinical Potential of Lorundrostat Across Cardio-Renal-Metabolic Diseases
Benzinga Newsdesk 11 months ago
News
– Late-breaking presentation of Explore-CKD trial at ASN Kidney Week –– Pivotal Phase 3 Launch-HTN trial featured in the "Best of JAMA and NEJM" session -
– Late-breaking presentation of Explore-CKD trial at ASN Kidney Week –
– Pivotal Phase 3 Launch-HTN trial featured in the "Best of JAMA and NEJM" session -